Iterative Health closed a $77 million Series C to accelerate clinical research.
- Amount
- $77M
- Stage
- Series C
- Announced
- 30 April 2026
- Leads
- Intrepid Growth Partners, GV (Google Ventures)
- Other investors
- EDBI, Insight Partners, Obvious Ventures
- Use of funds
- The new funding will support expansion into additional therapeutic areas beyond gastroenterology and hepatology, as well as continued geographic growth.
- Checked
- Amount and date checked against the press source